1329 related articles for article (PubMed ID: 19133767)
1. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.
Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C
J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455
[TBL] [Abstract][Full Text] [Related]
3. Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.
Deraeve C; Boldron C; Maraval A; Mazarguil H; Gornitzka H; Vendier L; Pitié M; Meunier B
Chemistry; 2008; 14(2):682-96. PubMed ID: 17969218
[TBL] [Abstract][Full Text] [Related]
4. Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease.
Lakatos A; Zsigó E; Hollender D; Nagy NV; Fülöp L; Simon D; Bozsó Z; Kiss T
Dalton Trans; 2010 Feb; 39(5):1302-15. PubMed ID: 20104357
[TBL] [Abstract][Full Text] [Related]
5. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
6. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
7. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
8. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.
Dedeoglu A; Cormier K; Payton S; Tseitlin KA; Kremsky JN; Lai L; Li X; Moir RD; Tanzi RE; Bush AI; Kowall NW; Rogers JT; Huang X
Exp Gerontol; 2004; 39(11-12):1641-9. PubMed ID: 15582280
[TBL] [Abstract][Full Text] [Related]
9. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Cherny RA; Barnham KJ; Lynch T; Volitakis I; Li QX; McLean CA; Multhaup G; Beyreuther K; Tanzi RE; Masters CL; Bush AI
J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226
[TBL] [Abstract][Full Text] [Related]
10. Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.
Lakatos A; Gyurcsik B; Nagy NV; Csendes Z; Wéber E; Fülöp L; Kiss T
Dalton Trans; 2012 Feb; 41(6):1713-26. PubMed ID: 22159144
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.
Han D; Wang H; Yang P
Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774
[TBL] [Abstract][Full Text] [Related]
12. Thioflavin-based molecular probes for application in Alzheimer's disease: from in silico to in vitro models.
Rodríguez-Rodríguez C; Telpoukhovskaia MA; Alí-Torres J; Rodríguez-Santiago L; Manso Y; Bailey GA; Hidalgo J; Sodupe M; Orvig C
Metallomics; 2015 Jan; 7(1):83-92. PubMed ID: 25325557
[TBL] [Abstract][Full Text] [Related]
13. Selective chelation of Cd(II) and Pb(II) versus Ca(II) and Zn(II) by using octadentate ligands containing pyridinecarboxylate and pyridyl pendants.
Ferreirós-Martínez R; Esteban-Gómez D; Platas-Iglesias C; de Blas A; Rodríguez-Blas T
Inorg Chem; 2009 Dec; 48(23):10976-87. PubMed ID: 19877597
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation.
Choi JS; Braymer JJ; Park SK; Mustafa S; Chae J; Lim MH
Metallomics; 2011 Mar; 3(3):284-91. PubMed ID: 21210061
[TBL] [Abstract][Full Text] [Related]
15. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
[TBL] [Abstract][Full Text] [Related]
16. The metal loading ability of beta-amyloid N-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue.
Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
Inorg Chem; 2008 Oct; 47(20):9669-83. PubMed ID: 18808108
[TBL] [Abstract][Full Text] [Related]
17. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.
Faller P; Hureau C
Dalton Trans; 2009 Feb; (7):1080-94. PubMed ID: 19322475
[TBL] [Abstract][Full Text] [Related]
18. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
Hou L; Zagorski MG
J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
[TBL] [Abstract][Full Text] [Related]
19. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease.
Liu ST; Howlett G; Barrow CJ
Biochemistry; 1999 Jul; 38(29):9373-8. PubMed ID: 10413512
[TBL] [Abstract][Full Text] [Related]
20. An improved screening model to identify inhibitors targeting zinc-enhanced amyloid aggregation.
Chang PT; Kung FL; Talekar RS; Chen CS; Lai SY; Lee HY; Chern JW
Anal Chem; 2009 Aug; 81(16):6944-51. PubMed ID: 19621898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
